Otostick - Innovaciones DisRas

What Otostick - Innovaciones DisRas does

INNOVACIONES DISRAS, S.L., operating commercially as Otostick, is a privately held Spanish company founded in 2008 by Paqui Gamero and headquartered in Don Benito, Badajoz. The company develops, manufactures, and commercializes a single product line of medical-grade silicone adhesive ear correctors sold under the Otostick (adults and children aged 3+) and Otostick Bebé (infants from 3 months) brands. These correctors are Class I Medical Devices certified by AEMPS, manufactured under ISO 13485:2016 quality standards, and clinically validated to achieve permanent corrective results in over 90% of cases among infants and children aged 3 months to 6 years, as published in the official journal of the Spanish Association of Pediatrics (PAP).

The business model is product-led and consumer-direct: revenue is generated through one-time unit-pack sales of 8-corrector packages (each corrector lasting 3-7 days), with no subscription component. Distribution is multi-channel and includes a proprietary e-commerce storefront (shop.otostick.com), an Amazon marketplace presence, a network of over 4,000 pharmacies across Spain (supported by a pharmacy locator tool), and international distributors covering more than 40 countries. The company operates as a Centro Especial de Empleo (Special Employment Center), with the majority of its workforce composed of persons with disabilities, and maintains a lean headcount of 5 employees.

The company is bootstrapped and founder-controlled, with no external institutional investors, acquisitions, or public listing plans disclosed. Multiple regional innovation and entrepreneurship awards (2008, 2010, 2012, 2018, 2023) underscore its regional recognition in Extremadura. Marketing is primarily digital and organic, leveraging social media, a blog (Actualidad), customer testimonials, and pharmacy professional recommendations as the primary acquisition levers, with no formal sales team.

Name

Otostick - Innovaciones DisRas

Legal name

INNOVACIONES DISRAS, S.L.

Website

https://otostick.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Otostick is a privately held Spanish medical-device company that designs, manufactures, and sells Class I-certified silicone adhesive ear correctors under the Otostick and Otostick Bebé brands, serving individual consumers (children and adults) seeking non-surgical correction of prominent ears via pharmacy, e-commerce, and international distributor channels in 40+ countries.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays) (CRADAMAG)

akta.pro secondary industries

Eye, Ear & Nasal Care (HLAIADAF), Ophthalmic & Otic Generics (HLAIABAF)

Keywords

• Ear correction devices
• Medical silicone correctors
• Aesthetic ear correction
• Non-surgical otoplasty
• Pediatric ear corrector

Headquarters

HQ city

Don Benito, Badajoz

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Others

Revenue model

1. Product Sales - Corrector Units: Otostick generates revenue primarily through the one-time sale of individual corrector units and multi-unit packs. The product is sold as a consumable with each package containing 8 correctors. Customers repurchase periodically as correctors are replaced every 3–7 days. Additional revenue comes from Otostick Bebé (baby variant). The model is direct-to-consumer and pharmacy-distributed with no subscription component.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Otostick manufactures and sells a medical-grade silicone adhesive corrector system designed to reposition prominent ears (orejas separadas / orejas de soplillo) through biomechanical fixation between the auricle and the scalp. The portfolio includes Otostick (for children aged 3+ and adults) in packages of 8 correctors with 3-7 day lifespan each, and Otostick Bebé (for infants from 3 months to 6 years), both certified as Class I Medical Devices by AEMPS and manufactured under ISO 13485:2016 standards.

Product overview

Otostick - Innovaciones DisRas offers a product portfolio centered on two silicone-based aesthetic ear correctors: Otostick (for children aged 3+ and adults) and Otostick Bebé (for infants and young children from 3 months). Both products consist of medical-grade silicone correctors with adhesive backing that adhere the ear to the adjacent scalp area, providing an immediate and natural aesthetic correction. The products are unisex, discreet (transparent silicone), painless, and can be used continuously or occasionally. The portfolio is manufactured under ISO 13485 medical device quality standards and is certified as Class I Medical Devices by the Spanish Agency of Medicines and Medical Products (AEMPS).

Differentiator

Problem solved

Functional benefit

Brands

• Otostick: Aesthetic corrector for protruding ears made of silicone and medical adhesives, designed for adults and children from 3 years old. Provides immediate and natural correction effect, is discreet, painless, and can be used continuously or for occasional events.
• Otostick Bebé

Products and services

• Otostick A silicone-based aesthetic corrector for protruding ears (orejas separadas/orejas de soplillo) for children aged 3+ and adults. Each package contains 8 correctors with a lifespan of 3-7 days per unit; the corrector adheres to the ear and adjacent scalp using medical-grade adhesive to provide immediate, natural aesthetic correction. Transparent, waterproof, sweat-resistant, and unisex.
• Otostick Bebé A pediatric version of the Otostick ear corrector specifically designed for babies and young children from 3 months old, with adapted sizing and softer materials suitable for delicate baby skin. Clinically tested demonstrating permanent corrective effect in over 90% of cases in infants and children aged 3 months to 6 years.

Quantifiable outcome

• Over 90% clinical efficacy in infants and children aged 3 months to 6 years, demonstrating a permanent corrective effect
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• 3M Health Care: US-based conglomerate with a major Health Care division encompassing medical adhesives, surgical tapes, skin barriers, and consumer health products; the broadest incumbent analog to Otostick's medical-grade adhesive technology stack and global pharmacy/retail distribution.
• Beiersdorf: German CPG company behind Eucerin, Hansaplast/Elastoplast, and NIVEA; comparable in consumer health/pharmacy retail distribution and OTC positioning, with similar use of medical-grade adhesives in wound care and a global multi-channel GTM.
• Sonova: Swiss global leader in hearing care (Phonak, Unitron) covering hearing aids, cochlear implants, and wireless communications; broad incumbent in ear-adjacent medical device space with overlapping pharmacy and clinic channels and far greater resources for R&D and global distribution.
• Demant: Danish hearing healthcare group (Oticon, Bernafon, Sonic, Philips Hearing Solutions); broad incumbent operating across the full ear-care value chain including hearing aids, implants, and diagnostic equipment, with extensive global retail and clinical distribution.
• Smith+Nephew: UK-based global medical device company with strong wound care, adhesive, and skin-adjacent franchises; comparable in medical-grade adhesive technology, ISO 13485 manufacturing, and hospital/pharmacy distribution for skin-contact medical products.
• Coloplast: Danish medical device company specializing in ostomy, wound care, continence, and skin-adhesive products; directly comparable in medical-grade adhesive/silicone device manufacturing under ISO 13485 with consumer-direct go-to-market in pharmacy and online channels.

Direct peers

• EarFold: Non-surgical ear correction implant system developed by Norbert Kang and acquired by Allergan; targets the same adult aesthetic ear correction market as Otostick but uses an implant-based mechanism rather than external adhesive, representing an alternative modality in the same category.
• EarBuddies: UK-based developer of EarBuddies splints, a non-surgical infant ear correction system using a different mechanical approach (splint-based) but addressing the same prominent-ear correction problem in babies; the most direct competitor to Otostick Bebé in the non-surgical pediatric ear correction niche.

Emerging players

• Biodermis: US-based manufacturer of medical-grade silicone adhesive products (Pro-Sil, Epi-Derm) for scar therapy and skin aesthetics; uses similar silicone + adhesive technology stack and direct-to-consumer + clinic distribution as Otostick, making it a strong parallel in adjacent aesthetic medical device categories.
• Tympa Health: UK-based digital ear and hearing health startup offering portable otoscopy and telehealth-enabled ear care diagnostics; emerging player addressing the broader ear-care consumer category that includes Otostick, though focused on examination rather than correction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/otostick---innovaciones-disras

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otostick - Innovaciones DisRas